Product Information
NIGHTTIME COLD-FLU RLF SFTGL is a generic product labeled by Major Pharmaceuticals, priced at $0.1192 per EA under NDC 00904699644. Its NADAC has been published 339 times since Apr 8, 2020.
NIGHTTIME COLD-FLU RLF SFTGL
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEStrength
325; 15; 6.25 mg/1; mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904699644
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
9/30/2019
Pharmacological Classes
Price Statistics
The NADAC for NIGHTTIME COLD-FLU RLF SFTGL has been published 339 times since Apr 8, 2020, and over the history we have for it it has declined 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1192 per EA |
|---|---|
| All-time high | $0.1613 (Sep 16, 2020) |
| All-time low | $0.1091 (Aug 18, 2021) |
| 52-week high | $0.1218 |
| 52-week low | $0.1182 |
| Median price | $0.1247 |
| Average price | $0.1282 |
| Largest weekly change | +33.7% (Aug 19, 2020) |
| Weeks tracked | 339 |
| Tracking since | Apr 8, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihistamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NIGHTTIME COLD-FLU RLF SFTGL?
The current National Average Drug Acquisition Cost (NADAC) for NIGHTTIME COLD-FLU RLF SFTGL, manufactured by Major Pharmaceuticals, is $0.1192 per EA (NDC 00904699644), effective Sep 30, 2026.
How has the price of NIGHTTIME COLD-FLU RLF SFTGL changed over time?
Over the history we have for it, the NADAC for NIGHTTIME COLD-FLU RLF SFTGL has declined 5.9%. It has been tracked across 339 weekly CMS publications since Apr 8, 2020.
What are the highest and lowest recorded NADAC prices for NIGHTTIME COLD-FLU RLF SFTGL?
Since Apr 8, 2020, the NADAC for NIGHTTIME COLD-FLU RLF SFTGL has ranged from a low of $0.1091 (Aug 18, 2021) to a high of $0.1613 (Sep 16, 2020), with a median of $0.1247 per EA.
Are there cheaper alternatives to NIGHTTIME COLD-FLU RLF SFTGL?
No other NADAC-published product currently shares the active ingredient and strength of NIGHTTIME COLD-FLU RLF SFTGL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NIGHTTIME COLD-FLU RLF SFTGL?
NIGHTTIME COLD-FLU RLF SFTGL (NDC 00904699644) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.